Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Beavis

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Nature Medicine|August 24, 2018
Publisher Correction: Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosisPeter Savas, Balaji Virassamy, Chengzhong Ye, et al.
Science Translational Medicine|April 5, 2023
T<sub>STEM</sub>-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical modelsDeborah Meyran, Joe Jiang Zhu, Jeanne Butler, et al.
Cancer Cell|September 30, 2022
Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responsesKah Lok Chan, Juliana Gomez, Chelisa Cardinez, et al.
Immunity|May 22, 2024
The CD8<sup>+</sup> T cell tolerance checkpoint triggers a distinct differentiation state defined by protein translation defectsWillem Van Der Byl, Simone Nüssing, Timothy J Peters, et al.
Cancer Cell|October 1, 2019
An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in CancerMarian L Burr, Christina E Sparbier, Kah Lok Chan, et al.
Nature Communications|November 2, 2023
A<sub>2A</sub>R eGFP reporter mouse enables elucidation of A<sub>2A</sub>R expression dynamics during anti-tumor immune responsesKirsten L Todd, Junyun Lai, Kevin Sek, et al.
Cell Reports|August 22, 2023
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunityImran G House, Emily B Derrick, Kevin Sek, et al.
Nature Immunology|February 10, 2026
Flt3L-mediated tumor cDC1 expansion enhances immunotherapy by priming stem-like CD8<sup>+</sup> T cells in lymph nodesJunyun Lai, Cheok Weng Chan, Jesse D Armitage, et al.
Nature Communications|August 7, 2021
MAIT cells regulate NK cell-mediated tumor immunityEmma V Petley, Hui-Fern Koay, Melissa A Henderson, et al.
Nature Communications|July 3, 2025
Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumorsKevin Sek, Amanda X Y Chen, Thomas Cole, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Nature Medicine|August 24, 2018
Publisher Correction: Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosisPeter Savas, Balaji Virassamy, Chengzhong Ye, et al.
Science Translational Medicine|April 5, 2023
T<sub>STEM</sub>-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical modelsDeborah Meyran, Joe Jiang Zhu, Jeanne Butler, et al.
Cancer Cell|September 30, 2022
Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responsesKah Lok Chan, Juliana Gomez, Chelisa Cardinez, et al.
Immunity|May 22, 2024
The CD8<sup>+</sup> T cell tolerance checkpoint triggers a distinct differentiation state defined by protein translation defectsWillem Van Der Byl, Simone Nüssing, Timothy J Peters, et al.
Cancer Cell|October 1, 2019
An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in CancerMarian L Burr, Christina E Sparbier, Kah Lok Chan, et al.
Nature Communications|November 2, 2023
A<sub>2A</sub>R eGFP reporter mouse enables elucidation of A<sub>2A</sub>R expression dynamics during anti-tumor immune responsesKirsten L Todd, Junyun Lai, Kevin Sek, et al.
Cell Reports|August 22, 2023
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunityImran G House, Emily B Derrick, Kevin Sek, et al.
Nature Immunology|February 10, 2026
Flt3L-mediated tumor cDC1 expansion enhances immunotherapy by priming stem-like CD8<sup>+</sup> T cells in lymph nodesJunyun Lai, Cheok Weng Chan, Jesse D Armitage, et al.
Nature Communications|August 7, 2021
MAIT cells regulate NK cell-mediated tumor immunityEmma V Petley, Hui-Fern Koay, Melissa A Henderson, et al.
Nature Communications|July 3, 2025
Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumorsKevin Sek, Amanda X Y Chen, Thomas Cole, et al.
Pageof 10